ALPANSEAlpa Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 20 Mar · 16:27 IST

Alpa Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

ALPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.0%1-day move
₹60.30
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-9.0-6.5-15.3-21.7-17.8+3.0+15.3+14.6+12.5+12.1
Up moveDown movePending
AI summary

Alpa Laboratories has informed the exchanges (NSE and BSE) that its trading window will remain closed from 1st April, 2026 until 48 hours after the announcement of its financial results for Q4 and the financial year ending March 31, 2026. The closure is in line with SEBI's Prohibition of Insider Trading Regulations and the company's internal code of conduct for insiders. The intimation was signed by Mahendra Singh Chawla, Whole Time Director, on 20th March, 2026. This is a routine compliance filing made ahead of the upcoming quarterly and annual results announcement.

Likely market impact

This is a standard regulatory disclosure and does not directly affect shareholders. However, during the trading window closure, insiders, promoters, and certain employees are barred from trading in the company's shares, which typically precedes the earnings announcement and may signal upcoming financial results.